Integrated Filing — IndAS



General information about company

Scrip Code 530019
NSE Symbol JUBLPHARMA
MSEI Symbol NOTLISTED
ISIN INE700A01033
Name of company JUBILANT PHARMOVA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 13-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 30-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharma
Start date and time of board meeting 13-11-2026   17:00:00
End date and time of board meeting 13-11-2026   18:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 06-02-2026
Indicate Company website link for updated RPT policy of the Company https://www.jubilantpharmova.com/investors/corporate-governance/policies-and-codes/policy-on-rpts
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No any Default



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 6,850.00 13,560.00
Other income 90.00 100.00
Total income 6,940.00 13,660.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 3,080.00 5,910.00
(e) Finance costs 100.00 190.00
(f) Depreciation, depletion and amortisation expense 130.00 270.00
(f) Other Expenses
1 Other Expenses 2,600.00 5,280.00
Total other expenses 2,600.00 5,280.00
Total expenses 5,910.00 11,650.00
3 Total profit before exceptional items and tax 1,030.00 2,010.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 1,030.00 2,010.00
6 Tax expense
7 Current tax 240.00 440.00
8 Deferred tax 30.00 80.00
9 Total tax expenses 270.00 520.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 760.00 1,490.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 760.00 1,490.00
17 Other comprehensive income net of taxes 10.00 20.00
18 Total Comprehensive Income for the period 770.00 1,510.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,590.00 1,590.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.48 0.94
Diluted earnings (loss) per share from continuing operations 0.48 0.94
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.48 0.94
Diluted earnings (loss) per share from continuing and discontinued operations 0.48 0.94
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 9,390.00
Capital work-in-progress 630.00
Investment property
Goodwill 0.00
Other intangible assets 210.00
Intangible assets under development 1,300.00
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 2,07,230.00
Trade receivables, non-current 0.00
Loans, non-current 8,630.00
Other non-current financial assets
1 other financial assets 800.00
Total of other non-current financial assets 800.00
Total non-current financial assets 2,16,660.00
Deferred tax assets (net) 4,470.00
Other non-current assets
1 Right of use assets 1,770.00
2 income tax assets 2,330.00
3 Other non-current assets 420.00
Total of other non-current assets 4,520.00
Total non-current assets 2,37,180.00
2 Current assets
Inventories 0.00
Current financial asset
Current investments 0.00
Trade receivables, current 5,340.00
Cash and cash equivalents 1,580.00
Bank balance other than cash and cash equivalents 0.00
Loans, current 10.00
Other current financial assets
Total of other current financial assets 50.00
Total current financial assets 6,980.00
Current tax assets (net)
Other current assets
1 Other current assets 1,600.00
Total of other current assets 1,600.00
Total current assets 8,580.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 2,45,760.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,590.00
Other equity 2,24,090.00
Total equity attributable to owners of parent 2,25,680.00
Non controlling interest
Total equity 2,25,680.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 5,000.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease Liablities 120.00
Total of other non-current financial liabilities 120.00
Total non-current financial liabilities 5,120.00
Provisions, non-current 1,210.00
Deferred tax liabilities (net)
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 6,330.00
Current liabilities
Current financial liabilities
Borrowings, current 4,530.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 50.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,350.00
Total Trade payable 1,400.00
Other current financial liabilities
1 Other financial liabilities 1,320.00
2 Lease Liabilities 120.00
Total of other current financial liabilities 1,440.00
Total current financial liabilities 7,370.00
Other current liabilities 4,580.00
1 Other current liabilities 4,580.00
Total of other current liabilities 4,580.00
Provisions, current 530.00
Current tax liabilities (Net) 1,270.00
Deferred government grants, Current 0.00
Total current liabilities 13,750.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 20,080.00
Total equity and liabilites 2,45,760.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 item that will not be reclassified to profit or loss 10.00 20.00
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
Total Amount of items that will not be reclassified to profit and loss 10.00 20.00
2 Income tax relating to items that will not be reclassified to profit or loss 0.00 0.00
3 Amount of items that will be reclassified to profit and loss
1 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
Total Amount of items that will be reclassified to profit and loss 0.00 0.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 10.00 20.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,010.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 190.00
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current (2,070.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 50.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 530.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 3,070.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 270.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 10.00
Adjustments for dividend income 0.00
Adjustments for interest income 50.00
Adjustments for share-based payments 130.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 2,130.00
Net cash flows from (used in) operations 4,140.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 750.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 3,390.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 1,120.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 8,620.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 30.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 10,380.00
Net cash flows from (used in) investing activities 670.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 4,530.00
Repayments of borrowings 0.00
Payments of lease liabilities 70.00
Dividends paid 7,940.00
Interest paid 30.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (3,510.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 550.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents 550.00
Cash and cash equivalents cash flow statement at beginning of period 1,030.00
Cash and cash equivalents cash flow statement at end of period 1,580.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Draximage (UK) Limited Jubilant DraxImage Inc. Immediate parent Any other transaction Other Receivable None 0.00 0.00 0.00
2 Draxis Pharma LLC Jubilant HollisterStier Inc. Immediate parent Any other transaction Loan Receivable None 0.00 234.20 236.70
3 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Any other transaction Interest Receivable None 0.00 372.10 164.40
4 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Any other transaction Loan Receivable None 0.00 8,961.90 7,675.60
5 Jubilant Biosys France SAS Jubilant Biosys Limited Immediate parent Any other transaction Trade payable None 0.00 19.60 25.20
6 Jubilant Biosys Innovative Research Services Pte Limited Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Interest Receivable None 0.00 416.10 392.30
7 Jubilant Biosys Innovative Research Services Pte Limited Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Loan Receivable None 0.00 2,845.10 2,874.80
8 Jubilant Biosys Limited Jubilant Biosys France SAS Subsidiary Any other transaction Trade payable None 0.00 168.80 286.70
9 Jubilant Biosys Limited Jubilant Biosys Innovative Research Services Pte Limited Subsidiary Any other transaction Interest Receivable None 0.00 520.60 329.80
10 Jubilant Biosys Limited Jubilant Biosys Innovative Research Services Pte Limited Subsidiary Any other transaction Loan Receivable None 0.00 2,845.10 2,874.80
11 Jubilant Biosys Limited Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Trade payable None 0.00 0.00 10.30
12 Jubilant Biosys Limited Jubilant Clinsys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 3.80
13 Jubilant Biosys Limited Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 58.50 65.60
14 Jubilant Biosys Limited Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Trade payable None 0.00 1,386.80 1,465.20
15 Jubilant Biosys Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 33.00 33.30
16 Jubilant Biosys Limited Jubilant Epicore LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 27.20 34.80
17 Jubilant Biosys Limited Jubilant Epipad LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 20.80 13.90
18 Jubilant Biosys Limited Jubilant Episcribe LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 78.90 0.00
19 Jubilant Biosys Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 31.20 0.00
20 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 597.90 692.70
21 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 15.90 18.20
22 Jubilant Biosys Limited Jubilant Life Sciences (Shanghai) Ltd Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 318.50 170.60
23 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Advance from Customers None 0.00 1,543.00 0.00
24 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 379.00 109.90
25 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 0.00 79.50
26 Jubilant Biosys Limited Jubilant Therapeutics India Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 22.20 31.90
27 Jubilant Biosys Limited O2 Renewable Energy XVI Private Limited Associates Any other transaction Trade payable None 0.00 321.60 338.30
28 Jubilant Biosys Limited TrialStat Solutions Inc. Step down subsidiary Any other transaction Other Receivable None 0.00 414.30 329.00
29 Jubilant Biosys Limited Jubilant Episcribe LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 0.00 4.30
30 Jubilant Business Services Limited Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Advance from Customers None 0.00 10.90 10.80
31 Jubilant Business Services Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.10 0.10
32 Jubilant Cadista Pharmaceuticals Inc. Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 7.60 7.70
33 Jubilant Cadista Pharmaceuticals Inc. Jubilant Biosys Limited Fellow subsidiary Any other transaction Trade payable None 0.00 1,332.20 853.80
34 Jubilant Cadista Pharmaceuticals Inc. Jubilant Business Services Limited Fellow subsidiary Any other transaction Trade payable None 0.00 18.90 19.10
35 Jubilant Cadista Pharmaceuticals Inc. Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.80 0.90
36 Jubilant Cadista Pharmaceuticals Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 54.50 65.80
37 Jubilant Cadista Pharmaceuticals Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 1.10 0.40
38 Jubilant Cadista Pharmaceuticals Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 35.10 35.50
39 Jubilant Cadista Pharmaceuticals Inc. Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 4.20
40 Jubilant Cadista Pharmaceuticals Inc. Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 1.40 1.50
41 Jubilant Cadista Pharmaceuticals Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 17.20 23.50
42 Jubilant Cadista Pharmaceuticals Inc. Jubilant Pharma ME FZ-LLC Fellow subsidiary Any other transaction Interest Receivable None 0.00 76.10 103.40
43 Jubilant Cadista Pharmaceuticals Inc. Jubilant Pharma ME FZ-LLC Fellow subsidiary Any other transaction Loan Receivable None 0.00 1,138.00 1,149.90
44 Jubilant Cadista Pharmaceuticals Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 1.90 1.90
45 Jubilant Clinsys Limited Jubilant DraxImage Limited Fellow subsidiary Any other transaction Interest Receivable None 0.00 2.30 5.00
46 Jubilant Clinsys Limited Jubilant DraxImage Limited Fellow subsidiary Any other transaction Loan Receivable None 0.00 96.00 96.00
47 Jubilant Clinsys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.10 0.00
48 Jubilant Discovery Services LLC Drug Discovery and Development Solutions Limited Intermediate parent Any other transaction Interest Receivable None 0.00 8.60 13.80
49 Jubilant Discovery Services LLC Drug Discovery and Development Solutions Limited Intermediate parent Any other transaction Loan Receivable None 0.00 284.50 287.50
50 Jubilant Discovery Services LLC Jubilant Clinsys Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 6.60 6.70
51 Jubilant Discovery Services LLC Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 19.20
52 Jubilant Discovery Services LLC TrialStat Solutions Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 31.10 67.40
53 Jubilant Draximage (USA) Inc. Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.60 0.60
54 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 87.80 476.00
55 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 6,229.10 5,891.40
56 Jubilant Draximage (USA) Inc. Jubilant HollisterStier Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.60 0.60
57 Jubilant Draximage (USA) Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 411.90 529.30
58 Jubilant DraxImage Inc. Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 3.00 3.00
59 Jubilant DraxImage Inc. Jubilant Business Services Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 64.90 65.60
60 Jubilant DraxImage Inc. Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 9.30 12.20
61 Jubilant DraxImage Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 35.80 36.60
62 Jubilant DraxImage Inc. Jubilant Draximage Radiopharmacies Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.70 0.70
63 Jubilant DraxImage Inc. Jubilant Generics Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 4.00 4.10
64 Jubilant DraxImage Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Advance to suppliers None 0.00 11,355.80 11,298.70
65 Jubilant DraxImage Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 951.70 342.00
66 Jubilant DraxImage Inc. Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 434.90 530.50
67 Jubilant DraxImage Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 51.10 67.10
68 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Interest Receivable None 0.00 7,366.50 6,272.60
69 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Loan Receivable None 0.00 1,08,111.90 1,09,241.00
70 Jubilant DraxImage Inc. Jubilant Pharma Limited Immediate parent Any other transaction Interest Receivable None 0.00 0.00 2,579.60
71 Jubilant DraxImage Inc. Jubilant Pharma Limited Immediate parent Any other transaction Loan Receivable None 0.00 1,69,730.90 1,71,503.50
72 Jubilant DraxImage Inc. Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Trade payable None 0.00 1.20 0.00
73 Jubilant DraxImage Inc. Jubilant Pharmaceutical Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 27.40 27.20
74 Jubilant DraxImage Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 0.10 0.10
75 Jubilant DraxImage Inc. TrialStat Solutions Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 9.40 6.20
76 Jubilant Draximage Radiopharmacies Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 9.50 9.60
77 Jubilant Draximage Radiopharmacies Inc. Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Interest Receivable None 0.00 1,053.60 1,157.60
78 Jubilant Draximage Radiopharmacies Inc. Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Loan Receivable None 0.00 4,267.60 4,312.10
79 Jubilant Employees Welfare Trust Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.20 0.20
80 Jubilant First Trust Healthcare Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.20 0.20
81 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 40.10 0.00
82 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Any other transaction Trade payable None 0.00 1,894.90 4,108.00
83 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 966.70 5,828.50
84 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 974.70 0.00
85 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 5,367.30 0.00
86 Jubilant Generics Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 8.60 0.00
87 Jubilant Generics Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 0.00 13.50
88 Jubilant Generics Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 25.80 35.30
89 Jubilant Generics Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 9.80 0.00
90 Jubilant Generics Limited Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 102.30 104.20
91 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 224.90 0.00
92 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Trade payable None 0.00 79.60 120.20
93 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 0.90 0.00
94 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 317.10 242.60
95 Jubilant Generics Limited Jubilant Pharma Australia Pty Limited Fellow subsidiary Any other transaction Trade payable None 0.00 22.80 4.40
96 Jubilant Generics Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 4.80 0.00
97 Jubilant Generics Limited Jubilant Pharma Limited Immediate parent Any other transaction Trade payable None 0.00 1,981.00 2,015.00
98 Jubilant Generics Limited Jubilant Pharma ME FZ-LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 321.80 360.50
99 Jubilant Generics Limited Jubilant Pharma SA (PTY) Limited Fellow subsidiary Any other transaction Trade Receivable None 0.00 274.80 334.10
100 Jubilant Generics Limited Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Trade Receivable None 0.00 2,193.70 2,293.50
101 Jubilant Generics Limited Jubilant Pharmaceuticals NV Step down subsidiary Any other transaction Trade payable None 0.00 194.30 35.10
102 Jubilant Generics Limited PSI Supply NV Step down subsidiary Any other transaction Trade Receivable None 0.00 509.60 611.20
103 Jubilant HollisterStier General Partnership Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 1.50 1.60
104 Jubilant HollisterStier General Partnership Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 48.20 48.70
105 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 1,202.80 253.60
106 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 273.40 365.70
107 Jubilant HollisterStier General Partnership Jubilant HollisterStier Inc. Immediate parent Any other transaction Other Receivable None 0.00 10.60 14.80
108 Jubilant HollisterStier General Partnership Jubilant HollisterStier Inc. Immediate parent Any other transaction Trade payable None 0.00 0.40 0.40
109 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 228.50 267.20
110 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 135.10 136.50
111 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Inter-corporate deposit None 0.00 6,638.60 6,707.70
112 Jubilant HollisterStier General Partnership Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 180.80 204.40
113 Jubilant HollisterStier General Partnership Jubilant Pharma Holdings Inc. Intermediate parent Any other transaction Other Receivable None 0.00 4.50 4.50
114 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Any other transaction Interest Receivable None 0.00 224.20 338.60
115 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Any other transaction Loan Receivable None 0.00 17,544.50 0.00
116 Jubilant HollisterStier LLC Draxis Pharma LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 1.40 1.40
117 Jubilant HollisterStier LLC Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 43.60 62.00
118 Jubilant HollisterStier LLC Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 373.90 430.20
119 Jubilant HollisterStier LLC Jubilant Clinsys Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 27.10 27.30
120 Jubilant HollisterStier LLC Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 170.60 182.90
121 Jubilant HollisterStier LLC Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 1,130.20 1,586.10
122 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 7.50 81.10
123 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 90.10 178.40
124 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 1,360.70 4,336.30
125 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Interest Receivable None 0.00 162.20 298.50
126 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Other Receivable None 0.00 685.60 837.80
127 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Trade Receivable None 0.00 74.60 75.40
128 Jubilant HollisterStier LLC Jubilant HollisterStier Inc. Fellow subsidiary Any other transaction Interest Receivable None 0.00 228.00 585.90
129 Jubilant HollisterStier LLC Jubilant HollisterStier Inc. Fellow subsidiary Any other transaction Loan Receivable None 0.00 17,544.60 17,727.80
130 Jubilant HollisterStier LLC Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 147.90 150.00
131 Jubilant HollisterStier LLC Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 4.80 10.20
132 Jubilant HollisterStier LLC Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 310.60 368.40
133 Jubilant HollisterStier LLC Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Other Receivable None 0.00 9,593.60 9,722.60
134 Jubilant HollisterStier LLC Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Trade payable None 0.00 21,722.30 4,361.10
135 Jubilant HollisterStier LLC Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 514.20 634.50
136 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Interest Receivable None 0.00 38.70 70.70
137 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Loan Receivable None 0.00 1,707.00 1,878.20
138 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Interest Receivable None 0.00 1,184.80 2,036.50
139 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Loan Receivable None 0.00 39,375.50 34,516.30
140 Jubilant Pharma Holdings Inc. Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 174.30 114.30
141 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Other Receivable None 0.00 6,912.80 6,413.10
142 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Trade payable None 0.00 550.20 547.60
143 Jubilant Pharma Holdings Inc. Jubilant Clinsys Inc. Subsidiary Any other transaction Other Receivable None 0.00 16.90 17.10
144 Jubilant Pharma Holdings Inc. Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 13.80 34.90
145 Jubilant Pharma Holdings Inc. Jubilant Draximage (USA) Inc. Subsidiary Any other transaction Other Receivable None 0.00 522.70 51.90
146 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 471.00 2,227.00
147 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 409.60 914.10
148 Jubilant Pharma Holdings Inc. Jubilant Draximage Radiopharmacies Inc. Subsidiary Any other transaction Other Receivable None 0.00 203.80 205.90
149 Jubilant Pharma Holdings Inc. Jubilant Generics Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 273.90 126.90
150 Jubilant Pharma Holdings Inc. Jubilant HollisterStier General Partnership Step down subsidiary Any other transaction Other Receivable None 0.00 622.80 667.60
151 Jubilant Pharma Holdings Inc. Jubilant HollisterStier Inc. Subsidiary Any other transaction Other Receivable None 0.00 68.20 68.90
152 Jubilant Pharma Holdings Inc. Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 49.40 50.60
153 Jubilant Pharma Holdings Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 510.70 477.70
154 Jubilant Pharma Holdings Inc. Jubilant Innovation (USA) Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 4.50 6.00
155 Jubilant Pharma Holdings Inc. Jubilant Pharma Limited Immediate parent Any other transaction Interest Receivable None 0.00 10.70 4,589.20
156 Jubilant Pharma Holdings Inc. Jubilant Pharma Limited Immediate parent Any other transaction Loan Receivable None 0.00 2,85,832.70 2,88,817.80
157 Jubilant Pharma Holdings Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Other Receivable None 0.00 31.10 43.00
158 Jubilant Pharma Limited Jubilant Cadista Pharmaceuticals Inc. Intermediate parent Any other transaction Other Receivable None 0.00 818.70 831.10
159 Jubilant Pharma Limited Jubilant DraxImage Inc. Subsidiary Any other transaction Other Receivable None 0.00 519.20 843.50
160 Jubilant Pharma Limited Jubilant Pharma Australia Pty Limited Subsidiary Any other transaction Other Receivable None 0.00 24.70 25.40
161 Jubilant Pharma Limited Jubilant Pharma Holdings Inc. Subsidiary Any other transaction Other Receivable None 0.00 1,171.20 0.00
162 Jubilant Pharma Limited Mr. Shyam S. Bhartia Key management personnel Any other transaction Bonus Payable None 0.00 1,618.50 825.60
163 Jubilant Pharma UK Limited Jubilant Biosys Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 15.30
164 Jubilant Pharmaceuticals NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 208.50 208.30
165 Jubilant Pharmaceuticals NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.60 0.60
166 Jubilant Pharmaceuticals NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 2.50 2.90
167 Jubilant Pharmaceuticals NV Jubilant Pharma NV Immediate parent Any other transaction Other Receivable None 0.00 103.90 106.00
168 Jubilant Pharmaceuticals NV PSI Supply NV Fellow subsidiary Any other transaction Other Receivable None 0.00 3.20 1.50
169 Jubilant Pharmova Limited Dr. Harsh Mahajan Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
170 Jubilant Pharmova Limited Drug Discovery and Development Solutions Limited Subsidiary Any other transaction Interest Receivable None 0.00 0.00 5.40
171 Jubilant Pharmova Limited Drug Discovery and Development Solutions Limited Subsidiary Any other transaction Loan Receivable None 0.00 0.00 8,624.30
172 Jubilant Pharmova Limited Jubilant Agri and Consumer Products Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 174.70 57.60
173 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Advance from Customers None 0.00 235.70 3,379.60
174 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Deposits payable None 0.00 100.00 100.00
175 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Trade Receivable None 0.00 269.30 0.00
176 Jubilant Pharmova Limited Jubilant Cadista Pharmaceuticals Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 239.20 357.00
177 Jubilant Pharmova Limited Jubilant Draximage (USA) Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 0.00 402.70
178 Jubilant Pharmova Limited Jubilant DraxImage Inc. Step down subsidiary Any other transaction Advance from Customers None 0.00 2.00 0.00
179 Jubilant Pharmova Limited Jubilant DraxImage Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 295.40 1,563.20
180 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Any other transaction Interest Payable None 0.00 63.90 214.00
181 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Any other transaction Trade Receivable None 0.00 45.90 20.30
182 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Inter-corporate deposit None 0.00 5,000.00 5,000.00
183 Jubilant Pharmova Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 15.00 64.70
184 Jubilant Pharmova Limited Jubilant First Trust Healthcare Limited Subsidiary Any other transaction Trade Receivable None 0.00 0.00 0.10
185 Jubilant Pharmova Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.80 0.00
186 Jubilant Pharmova Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 122.90 0.00
187 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Any other transaction Trade Receivable None 0.00 278.10 377.20
188 Jubilant Pharmova Limited Jubilant HollisterStier General Partnership Step down subsidiary Any other transaction Trade Receivable None 0.00 353.80 323.90
189 Jubilant Pharmova Limited Jubilant HollisterStier LLC Step down subsidiary Any other transaction Trade Receivable None 0.00 206.00 2,156.90
190 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Deposits payable None 0.00 50.00 50.00
191 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade Receivable None 0.00 348.00 11.60
192 Jubilant Pharmova Limited Jubilant Pharma Holdings Inc. Step down subsidiary Any other transaction Trade Receivable None 0.00 26.80 0.00
193 Jubilant Pharmova Limited Mr. Arun Seth Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
194 Jubilant Pharmova Limited Mr. Hari S. Bhartia Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
195 Jubilant Pharmova Limited Mr. Shirish G. Belapure Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
196 Jubilant Pharmova Limited Mr. Shyam S. Bhartia Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
197 Jubilant Pharmova Limited Mr. Sushil Kumar Roongta Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
198 Jubilant Pharmova Limited Mr. Vivek Mehra Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
199 Jubilant Pharmova Limited Ms. Shivpriya Nanda Key management personnel Any other transaction Commission payable None 0.00 15.00 0.00
200 Jubilant Therapeutics Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Other Receivable None 0.00 0.00 6,869.00
201 Jubilant Therapeutics Inc. Jubilant Epicore LLC Subsidiary Any other transaction Other Receivable None 0.00 1,346.10 1,802.60
202 Jubilant Therapeutics Inc. Jubilant Epipad LLC Subsidiary Any other transaction Other Receivable None 0.00 562.20 610.60
203 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Subsidiary Any other transaction Other Receivable None 0.00 573.00 0.00
204 Jubilant Therapeutics Inc. Jubilant Prodel LLC Subsidiary Any other transaction Other Receivable None 0.00 79.20 0.00
205 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 651.00
206 Jubilant Therapeutics Inc. Jubilant Prodel LLC Fellow subsidiary Any other transaction Other Receivable None 0.00 0.00 80.30
207 Jubilant Therapeutics India Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 0.60 0.50
208 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Any other transaction Interest Receivable None 0.00 68.50 171.30
209 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Any other transaction Trade Receivable None 0.00 537.70 479.10
210 Jubilant Therapeutics India Limited TrialStat Solutions Inc. Fellow subsidiary Any other transaction Trade payable None 0.00 73.70 86.70
211 Jubilant Therapeutics India Limited Jubilant Episcribe LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 0.00 34.50
212 Jubilant Therapeutics India Limited Jubilant Prodel LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 0.00 6.90
213 PSI Supply NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 16.30 16.20
214 PSI Supply NV Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Trade payable None 0.00 109.00 108.90
215 PSI Supply NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 0.60 0.40
216 PSI Supply NV Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Other Receivable None 0.00 189.00 0.00
217 PSI Supply NV Jubilant Pharmaceuticals NV Fellow subsidiary Any other transaction Other Receivable None 0.00 1,434.40 1,464.30
218 TrialStat Solutions Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Trade Receivable None 0.00 814.40 944.40
219 TrialStat Solutions Inc. Jubilant Epicore LLC Fellow subsidiary Any other transaction Trade Receivable None 0.00 164.20 185.50
220 TrialStat Solutions Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Other Receivable None 0.00 15.70 15.80
221 Drug Discovery and Development Solutions Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Borrowings repaid 0.00 None 8,602.60 0.00 0.00
222 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Any other transaction Loans given 10,400.00 None 3,393.50 0.00 0.00 Loan 4.2400 6 years Loan 4.3900 4 years Unsecured Business Purpose
223 Drug Discovery and Development Solutions Limited Jubilant Therapeutics Inc. Subsidiary Interest received 600.00 None 189.20 0.00 0.00
224 Drug Discovery and Development Solutions Limited Jubilant Episcribe LLC Subsidiary Investment 0.00 None 133.80 0.00 0.00 Loan 4.3500 7 years Investment 0 NA Unsecured Business Purpose
225 Drug Discovery and Development Solutions Limited Jubilant Prodel LLC Subsidiary Investment 0.00 None 47.80 0.00 0.00 Loan 4.3500 7 years Investment 0 NA Unsecured Business Purpose
226 Jubilant Biosys France SAS Jubilant Biosys Limited Immediate parent Any other transaction Other income 700.00 None 119.40 0.00 0.00
227 Jubilant Biosys Innovative Research Services Pte Limited Drug Discovery and Development Solutions Limited Fellow subsidiary Interest received 0.00 None 124.30 0.00 0.00
228 Jubilant Biosys Innovative Research Services Pte Limited Jubilant Biosys France SAS Subsidiary Investment 1,700.00 None 1,599.20 0.00 0.00 Investment 0 NA Unsecured Business purpose
229 Jubilant Biosys Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 150.00 None 39.30 0.00 0.00
230 Jubilant Biosys Limited Jubilant Biosys France SAS Subsidiary Sale of goods or services 1,000.00 None 4.30 0.00 0.00
231 Jubilant Biosys Limited Jubilant Biosys Innovative Research Services Pte Limited Subsidiary Interest received 250.00 None 121.50 0.00 0.00
232 Jubilant Biosys Limited Jubilant Biosys Innovative Research Services Pte Limited Subsidiary Investment 1,700.00 None 1,660.90 0.00 0.00 Investment 0 NA Unsecured Business purpose
233 Jubilant Biosys Limited Jubilant Cadista Pharmaceuticals Inc. Subsidiary Sale of goods or services 1,500.00 None 305.00 0.00 0.00
234 Jubilant Biosys Limited Jubilant Clinsys Limited Fellow subsidiary Any other transaction Recovery of Expenses 5.00 None 3.70 0.00 0.00
235 Jubilant Biosys Limited Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Reimbursement of expenses 2,500.00 None 1,404.90 0.00 0.00
236 Jubilant Biosys Limited Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Other income 200.00 None 2.40 0.00 0.00
237 Jubilant Biosys Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 15.00 None 6.00 0.00 0.00
238 Jubilant Biosys Limited Jubilant Epicore LLC Fellow subsidiary Sale of goods or services 800.00 None 11.90 0.00 0.00
239 Jubilant Biosys Limited Jubilant Epipad LLC Fellow subsidiary Sale of goods or services 500.00 None 13.80 0.00 0.00
240 Jubilant Biosys Limited Jubilant Generics Limited Fellow subsidiary Any other transaction Reimbursement of expenses 150.00 None 11.60 0.00 0.00
241 Jubilant Biosys Limited Jubilant Generics Limited Fellow subsidiary Sale of goods or services 7,500.00 None 3,422.10 0.00 0.00
242 Jubilant Biosys Limited Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Reimbursement of expenses 100.00 None 17.80 0.00 0.00
243 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 50.00 None 1.10 0.00 0.00
244 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 1,050.00 None 478.20 0.00 0.00
245 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Purchase of goods or services 1,100.00 None 238.20 0.00 0.00
246 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Sale of fixed assets 30.00 None 22.40 0.00 0.00
247 Jubilant Biosys Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Sale of goods or services 50.00 None 2.10 0.00 0.00
248 Jubilant Biosys Limited Jubilant Life Sciences (Shanghai) Ltd Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 500.00 None 145.70 0.00 0.00
249 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Purchase of goods or services 500.00 None 222.10 0.00 0.00
250 Jubilant Biosys Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Sale of goods or services 20,000.00 None 1,731.60 0.00 0.00
251 Jubilant Biosys Limited Jubilant Pharma UK Limited Fellow subsidiary Purchase of goods or services 300.00 None 15.30 0.00 0.00
252 Jubilant Biosys Limited Jubilant Therapeutics India Limited Fellow subsidiary Any other transaction Rental and other income 20.00 None 10.70 0.00 0.00
253 Jubilant Biosys Limited O2 Renewable Energy XVI Private Limited Associates Purchase of goods or services 2,400.00 None 1,085.30 0.00 0.00
254 Jubilant Biosys Limited TrialStat Solutions Inc. Step down subsidiary Any other transaction Other income 500.00 None 196.30 0.00 0.00
255 Jubilant Biosys Limited Jubilant Episcribe LLC Fellow subsidiary Sale of goods or services 800.00 None 4.30 0.00 0.00
256 Jubilant Cadista Pharmaceuticals Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 10.70 0.00 0.00
257 Jubilant Cadista Pharmaceuticals Inc. Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 4.10 0.00 0.00
258 Jubilant Cadista Pharmaceuticals Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 6.10 0.00 0.00
259 Jubilant Cadista Pharmaceuticals Inc. Jubilant Pharma ME FZ-LLC Fellow subsidiary Interest received 0.00 None 26.30 0.00 0.00
260 Jubilant Clinsys Limited Jubilant DraxImage Limited Fellow subsidiary Interest received 0.00 None 3.10 0.00 0.00
261 Jubilant Discovery Services LLC Drug Discovery and Development Solutions Limited Intermediate parent Interest received 0.00 None 5.10 0.00 0.00
262 Jubilant Discovery Services LLC TrialStat Solutions Inc. Fellow subsidiary Any other transaction Other income 0.00 None 117.30 0.00 0.00
263 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 663.00 0.00 0.00
264 Jubilant Draximage (USA) Inc. Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 7,271.80 0.00 0.00
265 Jubilant DraxImage Inc. Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 2.70 0.00 0.00
266 Jubilant DraxImage Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 0.40 0.00 0.00
267 Jubilant DraxImage Inc. Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 278.30 0.00 0.00
268 Jubilant DraxImage Inc. Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 138.60 0.00 0.00
269 Jubilant DraxImage Inc. Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 88.00 0.00 0.00
270 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 76.70 0.00 0.00
271 Jubilant DraxImage Inc. Jubilant Pharma Holdings Inc. Fellow subsidiary Interest received 0.00 None 3,592.80 0.00 0.00
272 Jubilant DraxImage Inc. Jubilant Pharma Limited Immediate parent Interest received 0.00 None 2,560.60 0.00 0.00
273 Jubilant DraxImage Inc. TrialStat Solutions Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 38.30 0.00 0.00
274 Jubilant Draximage Radiopharmacies Inc. Jubilant Pharma Holdings Inc. Immediate parent Interest received 0.00 None 92.30 0.00 0.00
275 Jubilant Generics Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 100.00 None 7.50 0.00 0.00
276 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Any other transaction Other income 1,000.00 None 441.30 0.00 0.00
277 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Investment 10,603.00 None 10,603.00 0.00 0.00 Investment 0 NA Unsecured Business purpose
278 Jubilant Generics Limited Jubilant Biosys Limited Fellow subsidiary Sale of fixed assets 12,100.00 None 10,711.40 0.00 0.00
279 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Recovery of Expenses 200.00 None 3.30 0.00 0.00
280 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Reimbursement of expenses 200.00 None 70.80 0.00 0.00
281 Jubilant Generics Limited Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Sale of goods or services 12,500.00 None 4,652.50 0.00 0.00
282 Jubilant Generics Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 100.00 None 2.00 0.00 0.00
283 Jubilant Generics Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Sale of goods or services 100.00 None 8.00 0.00 0.00
284 Jubilant Generics Limited Jubilant HollisterStier General Partnership Fellow subsidiary Sale of goods or services 100.00 None 2.90 0.00 0.00
285 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Purchase of goods or services 200.00 None 58.20 0.00 0.00
286 Jubilant Generics Limited Jubilant HollisterStier LLC Fellow subsidiary Sale of goods or services 100.00 None 18.90 0.00 0.00
287 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 50.00 None 1.10 0.00 0.00
288 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 450.00 None 142.40 0.00 0.00
289 Jubilant Generics Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Purchase of goods or services 150.00 None 0.00 0.00 0.00
290 Jubilant Generics Limited Jubilant Pharma Australia Pty Limited Fellow subsidiary Any other transaction Recovery of Expenses 100.00 None 5.20 0.00 0.00
291 Jubilant Generics Limited Jubilant Pharma Australia Pty Limited Fellow subsidiary Purchase of goods or services 100.00 None 5.90 0.00 0.00
292 Jubilant Generics Limited Jubilant Pharma Holdings Inc. Fellow subsidiary Purchase of goods or services 300.00 None 117.00 0.00 0.00
293 Jubilant Generics Limited Jubilant Pharma Limited Immediate parent Any other transaction Recovery of Expenses 100.00 None 2.10 0.00 0.00
294 Jubilant Generics Limited Jubilant Pharma Limited Immediate parent Any other transaction Reimbursement of expenses 1,200.00 None 831.10 0.00 0.00
295 Jubilant Generics Limited Jubilant Pharma ME FZ-LLC Fellow subsidiary Sale of goods or services 2,000.00 None 35.00 0.00 0.00
296 Jubilant Generics Limited Jubilant Pharma SA (PTY) Limited Fellow subsidiary Sale of goods or services 2,500.00 None 45.00 0.00 0.00
297 Jubilant Generics Limited Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Reimbursement of expenses 100.00 None 59.80 0.00 0.00
298 Jubilant Generics Limited Jubilant Pharma UK Limited Fellow subsidiary Sale of goods or services 12,400.00 None 4,226.80 0.00 0.00
299 Jubilant Generics Limited Jubilant Pharmaceuticals NV Step down subsidiary Any other transaction Reimbursement of expenses 800.00 None 175.80 0.00 0.00
300 Jubilant Generics Limited Mr. Shirish G. Belapure Key management personnel Any other transaction Sitting fees and director fees 0.00 None 2.80 0.00 0.00
301 Jubilant Generics Limited PSI Supply NV Step down subsidiary Any other transaction Reimbursement of expenses 300.00 None 11.70 0.00 0.00
302 Jubilant Generics Limited PSI Supply NV Step down subsidiary Sale of goods or services 3,000.00 None 859.30 0.00 0.00
303 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 1,249.10 0.00 0.00
304 Jubilant HollisterStier General Partnership Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 1,319.40 0.00 0.00
305 Jubilant HollisterStier General Partnership Jubilant HollisterStier Inc. Immediate parent Any other transaction Recovery of Expenses 0.00 None 4.00 0.00 0.00
306 Jubilant HollisterStier General Partnership Jubilant HollisterStier LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 43.10 0.00 0.00
307 Jubilant HollisterStier General Partnership Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 25.40 0.00 0.00
308 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Interest received 0.00 None 110.70 0.00 0.00
309 Jubilant HollisterStier Inc. Jubilant HollisterStier General Partnership Subsidiary Investment 0.00 None 28,484.10 0.00 0.00 Investment 0 NA Unsecured Business purpose
310 Jubilant HollisterStier LLC Jubilant Cadista Pharmaceuticals Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 52.00 0.00 0.00
311 Jubilant HollisterStier LLC Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 102.80 0.00 0.00
312 Jubilant HollisterStier LLC Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 441.10 0.00 0.00
313 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 12.80 0.00 0.00
314 Jubilant HollisterStier LLC Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 4,765.80 0.00 0.00
315 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 143.80 0.00 0.00
316 Jubilant HollisterStier LLC Jubilant HollisterStier General Partnership Fellow subsidiary Interest received 0.00 None 133.50 0.00 0.00
317 Jubilant HollisterStier LLC Jubilant HollisterStier Inc. Fellow subsidiary Interest received 0.00 None 352.90 0.00 0.00
318 Jubilant HollisterStier LLC Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 0.60 0.00 0.00
319 Jubilant HollisterStier LLC Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 5.30 0.00 0.00
320 Jubilant HollisterStier LLC Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.00 None 52.30 0.00 0.00
321 Jubilant HollisterStier LLC Jubilant Pharma Holdings Inc. Immediate parent Any other transaction Recovery of Expenses 0.00 None 28.60 0.00 0.00
322 Jubilant HollisterStier LLC Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Recovery of Expenses 300.00 None 113.90 0.00 0.00
323 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Loans given 0.00 None 152.90 0.00 0.00 Loan 4.3500 7 years Unsecured Business Purpose
324 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Reimbursement of expenses 0.00 None 1.50 0.00 0.00
325 Jubilant Innovation (USA) Inc. Drug Discovery and Development Solutions Limited Immediate parent Interest received 0.00 None 31.40 0.00 0.00
326 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Any other transaction Loans given 0.00 None 3,336.10 0.00 0.00 Loan 4.2400 6 years Unsecured Business Purpose
327 Jubilant Pharma Holdings Inc. Drug Discovery and Development Solutions Limited Fellow subsidiary Interest received 0.00 None 833.40 0.00 0.00
328 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 132.80 0.00 0.00
329 Jubilant Pharma Holdings Inc. Jubilant Cadista Pharmaceuticals Inc. Subsidiary Sale of goods or services 0.00 None 435.40 0.00 0.00
330 Jubilant Pharma Holdings Inc. Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 20.80 0.00 0.00
331 Jubilant Pharma Holdings Inc. Jubilant Draximage (USA) Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 82.10 0.00 0.00
332 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 972.70 0.00 0.00
333 Jubilant Pharma Holdings Inc. Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 1,329.50 0.00 0.00
334 Jubilant Pharma Holdings Inc. Jubilant HollisterStier General Partnership Step down subsidiary Any other transaction Recovery of Expenses 0.00 None 16.20 0.00 0.00
335 Jubilant Pharma Holdings Inc. Jubilant HollisterStier General Partnership Step down subsidiary Sale of goods or services 0.00 None 21.90 0.00 0.00
336 Jubilant Pharma Holdings Inc. Jubilant HollisterStier Inc. Subsidiary Investment 0.00 None 10,973.50 0.00 0.00 Loan 5.6900 5 years Investment 0 NA Unsecured Business purpose
337 Jubilant Pharma Holdings Inc. Jubilant HollisterStier LLC Subsidiary Any other transaction Recovery of Expenses 0.00 None 3,489.60 0.00 0.00
338 Jubilant Pharma Holdings Inc. Jubilant HollisterStier LLC Subsidiary Sale of goods or services 0.00 None 2,837.70 0.00 0.00
339 Jubilant Pharma Holdings Inc. Jubilant Industries Inc. USA Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 0.70 0.00 0.00
340 Jubilant Pharma Holdings Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 2.10 0.00 0.00
341 Jubilant Pharma Holdings Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Sale of goods or services 0.00 None 57.70 0.00 0.00
342 Jubilant Pharma Holdings Inc. Jubilant Pharma Limited Immediate parent Interest received 0.00 None 4,544.70 0.00 0.00
343 Jubilant Pharma Holdings Inc. Jubilant Therapeutics Inc. Fellow subsidiary Any other transaction Recovery of Expenses 100.00 None 11.60 0.00 0.00
344 Jubilant Pharma Limited Jubilant Cadista Pharmaceuticals Inc. Intermediate parent Any other transaction Recovery of Expenses 0.00 None 829.00 0.00 0.00
345 Jubilant Pharma Limited Jubilant DraxImage Inc. Subsidiary Any other transaction Recovery of Expenses 0.00 None 184.20 0.00 0.00
346 Jubilant Pharma Limited Jubilant DraxImage Inc. Subsidiary Sale of goods or services 0.00 None 1,307.90 0.00 0.00
347 Jubilant Pharma Limited Jubilant Pharma Holdings Inc. Subsidiary Sale of goods or services 0.00 None 1,307.90 0.00 0.00
348 Jubilant Pharma Limited Mr. Shyam S. Bhartia Key management personnel Remuneration 3,500.00 None 1,763.70 0.00 0.00
349 Jubilant Pharmaceuticals NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 60.00 None 17.50 0.00 0.00
350 Jubilant Pharmaceuticals NV PSI Supply NV Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 8.90 0.00 0.00
351 Jubilant Pharmova Limited Dr. Harsh Mahajan Key management personnel Any other transaction Sitting fees and director fees 0.00 None 5.00 0.00 0.00
352 Jubilant Pharmova Limited Drug Discovery and Development Solutions Limited Subsidiary Any other transaction Loans given 0.00 Exempt transaction with wholly owned subsidiary 8,622.70 0.00 0.00 Loan 7.5500 3 years Unsecured Business purpose
353 Jubilant Pharmova Limited Drug Discovery and Development Solutions Limited Subsidiary Interest received 0.00 None 5.40 0.00 0.00
354 Jubilant Pharmova Limited Jubilant Agri and Consumer Products Limited Enterprise in which Key management personnel are interested Sale of goods or services 900.00 None 395.70 0.00 0.00
355 Jubilant Pharmova Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 200.00 None 37.80 0.00 0.00
356 Jubilant Pharmova Limited Jubilant Bhartia Foundation Other related party Sale of goods or services 100.00 None 14.20 0.00 0.00
357 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Recovery of Expenses 300.00 None (66.40) 0.00 0.00
358 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Any other transaction Reimbursement of expenses 100.00 None 10.40 0.00 0.00
359 Jubilant Pharmova Limited Jubilant Biosys Limited Subsidiary Sale of goods or services 9,300.00 None 4,071.00 0.00 0.00
360 Jubilant Pharmova Limited Jubilant Business Services Limited Subsidiary Any other transaction Reimbursement of expenses 100.00 None 0.10 0.00 0.00
361 Jubilant Pharmova Limited Jubilant Cadista Pharmaceuticals Inc. Step down subsidiary Sale of goods or services 900.00 None 430.90 0.00 0.00
362 Jubilant Pharmova Limited Jubilant Consumer Private Limited Enterprise in which Key management personnel are interested Sale of goods or services 100.00 None 9.30 0.00 0.00
363 Jubilant Pharmova Limited Jubilant Draximage (USA) Inc. Step down subsidiary Any other transaction Recovery of Expenses 1,500.00 None 722.60 0.00 0.00
364 Jubilant Pharmova Limited Jubilant DraxImage Inc. Step down subsidiary Sale of goods or services 6,100.00 None 3,097.40 0.00 0.00
365 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Any other transaction Recovery of Expenses 200.00 None 32.70 0.00 0.00
366 Jubilant Pharmova Limited Jubilant Employees Welfare Trust Subsidiary Interest paid 500.00 None 166.70 0.00 0.00
367 Jubilant Pharmova Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 100.00 None 2.50 0.00 0.00
368 Jubilant Pharmova Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Sale of goods or services 200.00 None 95.90 0.00 0.00
369 Jubilant Pharmova Limited Jubilant First Trust Healthcare Limited Subsidiary Any other transaction Recovery of Expenses 100.00 None 0.10 0.00 0.00
370 Jubilant Pharmova Limited Jubilant FoodWorks Limited Enterprise in which Key management personnel are interested Sale of goods or services 2,200.00 None 889.90 0.00 0.00
371 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Any other transaction Recovery of Expenses 500.00 None 156.10 0.00 0.00
372 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Any other transaction Reimbursement of expenses 100.00 None 1.60 0.00 0.00
373 Jubilant Pharmova Limited Jubilant Generics Limited Step down subsidiary Sale of goods or services 1,600.00 None 763.70 0.00 0.00
374 Jubilant Pharmova Limited Jubilant HollisterStier General Partnership Step down subsidiary Sale of goods or services 700.00 None 88.50 0.00 0.00
375 Jubilant Pharmova Limited Jubilant HollisterStier LLC Step down subsidiary Sale of goods or services 6,200.00 None 2,991.30 0.00 0.00
376 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 400.00 None 151.50 0.00 0.00
377 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 100.00 None 20.60 0.00 0.00
378 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 700.00 None 221.40 0.00 0.00
379 Jubilant Pharmova Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Sale of goods or services 4,800.00 None 1,960.80 0.00 0.00
380 Jubilant Pharmova Limited Mr. Arjun Shanker Bhartia Key management personnel Remuneration 750.00 None 374.80 0.00 0.00
381 Jubilant Pharmova Limited Mr. Arun Kumar Sharma Key management personnel Remuneration 0.00 None 28.50 0.00 0.00
382 Jubilant Pharmova Limited Mr. Arun Seth Key management personnel Any other transaction Sitting fees and director fees 0.00 None 7.00 0.00 0.00
383 Jubilant Pharmova Limited Mr. Ashish Omprakash Mukkirwar Key management personnel Remuneration 0.00 None 394.40 0.00 0.00
384 Jubilant Pharmova Limited Mr. Hari S. Bhartia Key management personnel Any other transaction Sitting fees and director fees 21.00 None 2.00 0.00 0.00
385 Jubilant Pharmova Limited Mr. Naresh Kapoor Key management personnel Remuneration 0.00 None 96.60 0.00 0.00
386 Jubilant Pharmova Limited Mr. Priyavrat Bhartia Key management personnel Remuneration 750.00 None 374.80 0.00 0.00
387 Jubilant Pharmova Limited Mr. Shirish G. Belapure Key management personnel Any other transaction Sitting fees and director fees 0.00 None 4.30 0.00 0.00
388 Jubilant Pharmova Limited Mr. Shyam S. Bhartia Key management personnel Any other transaction Sitting fees and director fees 24.00 None 2.80 0.00 0.00
389 Jubilant Pharmova Limited Mr. Sushil Kumar Roongta Key management personnel Any other transaction Sitting fees and director fees 0.00 None 7.00 0.00 0.00
390 Jubilant Pharmova Limited Mr. Vivek Mehra Key management personnel Any other transaction Sitting fees and director fees 0.00 None 5.50 0.00 0.00
391 Jubilant Pharmova Limited Ms. Shivpriya Nanda Key management personnel Any other transaction Sitting fees and director fees 0.00 None 4.30 0.00 0.00
392 Jubilant Therapeutics Inc. Drug Discovery and Development Solutions Limited Immediate parent Any other transaction Borrowings repaid 4,833.30 None 4,779.20 0.00 0.00
393 Jubilant Therapeutics Inc. Drug Discovery and Development Solutions Limited Immediate parent Investment 14,500.00 None 14,337.60 0.00 0.00
394 Jubilant Therapeutics Inc. Jubilant Discovery Services LLC Fellow subsidiary Any other transaction Reimbursement of expenses 100.00 None 18.90 0.00 0.00
395 Jubilant Therapeutics Inc. Jubilant Draximage (USA) Inc. Fellow subsidiary Any other transaction Reimbursement of expenses 300.00 None 112.20 0.00 0.00
396 Jubilant Therapeutics Inc. Jubilant Epicore LLC Subsidiary Any other transaction Recovery of Expenses 2,000.00 None 439.90 0.00 0.00
397 Jubilant Therapeutics Inc. Jubilant Epicore LLC Subsidiary Investment 2,900.00 None 839.30 0.00 0.00 Loan 4.3900 4 years Investment 0 NA Unsecured Business purpose
398 Jubilant Therapeutics Inc. Jubilant Epipad LLC Subsidiary Any other transaction Recovery of Expenses 200.00 None 42.30 0.00 0.00
399 Jubilant Therapeutics Inc. Jubilant Epipad LLC Subsidiary Investment 500.00 None 20.90 0.00 0.00 Loan 4.3900 4 years Investment 0 NA Unsecured Business purpose
400 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Subsidiary Any other transaction Recovery of Expenses 500.00 None 62.30 0.00 0.00
401 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Subsidiary Investment 1,500.00 None 22.70 0.00 0.00 Loan 4.3900 4 years Investment 0 NA Unsecured Business purpose
402 Jubilant Therapeutics Inc. Jubilant Prodel LLC Subsidiary Investment 500.00 None 17.00 0.00 0.00 Loan 4.3900 4 years Investment 0 NA Unsecured Business purpose
403 Jubilant Therapeutics Inc. Jubilant Episcribe LLC Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 8.90 0.00 0.00
404 Jubilant Therapeutics Inc. Jubilant Prodel LLC Fellow subsidiary Any other transaction Recovery of Expenses 100.00 None 0.20 0.00 0.00
405 Jubilant Therapeutics India Limited Jubilant Bhartia Foundation Other related party Any other transaction Donation 2.00 None 1.00 0.00 0.00
406 Jubilant Therapeutics India Limited Jubilant Enpro Private Limited Enterprise in which Key management personnel are interested Any other transaction Reimbursement of expenses 0.30 None 0.00 0.00 0.00
407 Jubilant Therapeutics India Limited Jubilant Ingrevia Limited Enterprise in which Key management personnel are interested Any other transaction Lease Payments 2.00 None 0.60 0.00 0.00
408 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Interest received 300.00 None 102.80 0.00 0.00
409 Jubilant Therapeutics India Limited Jubilant Therapeutics Inc. Associates Sale of goods or services 1,000.00 None 370.60 0.00 0.00
410 Jubilant Therapeutics India Limited Jubilant Episcribe LLC Fellow subsidiary Sale of goods or services 200.00 None 34.60 0.00 0.00
411 Jubilant Therapeutics India Limited Jubilant Prodel LLC Fellow subsidiary Sale of goods or services 50.00 None 6.90 0.00 0.00
412 PSI Supply NV Jubilant Life Sciences NV Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 0.00 None 2.00 0.00 0.00
413 PSI Supply NV Jubilant Pharma UK Limited Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 63.50 0.00 0.00
414 PSI Supply NV Jubilant Pharma UK Limited Fellow subsidiary Sale of goods or services 0.00 None 138.10 0.00 0.00
415 PSI Supply NV Jubilant Pharmaceuticals NV Fellow subsidiary Any other transaction Recovery of Expenses 0.00 None 10.10 0.00 0.00
416 TrialStat Solutions Inc. Jubilant DraxImage Inc. Fellow subsidiary Sale of goods or services 0.00 None 850.60 0.00 0.00
417 TrialStat Solutions Inc. Jubilant Epicore LLC Fellow subsidiary Sale of goods or services 200.00 None 19.60 0.00 0.00
418 TrialStat Solutions Inc. Jubilant Ingrevia (USA) Inc. Enterprise in which Key management personnel are interested Any other transaction Recovery of Expenses 400.00 None 123.40 0.00 0.00
419 TrialStat Solutions Inc. Jubilant Therapeutics India Limited Fellow subsidiary Sale of goods or services 100.00 None 12.20 0.00 0.00
Total value of transaction during the reporting period 1,94,248.70